First Time Loading...

Fate Therapeutics Inc
NASDAQ:FATE

Watchlist Manager
Fate Therapeutics Inc Logo
Fate Therapeutics Inc
NASDAQ:FATE
Watchlist
Price: 4.15 USD 1.72% Market Closed
Updated: May 14, 2024

Fate Therapeutics Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fate Therapeutics Inc
EPS (Diluted) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Fate Therapeutics Inc
NASDAQ:FATE
EPS (Diluted)
-$1
CAGR 3-Years
8%
CAGR 5-Years
-7%
CAGR 10-Years
-4%
Abbvie Inc
NYSE:ABBV
EPS (Diluted)
$2
CAGR 3-Years
0%
CAGR 5-Years
-6%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
EPS (Diluted)
$0
CAGR 3-Years
18%
CAGR 5-Years
-39%
CAGR 10-Years
-18%
Amgen Inc
NASDAQ:AMGN
EPS (Diluted)
$7
CAGR 3-Years
-17%
CAGR 5-Years
-11%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
EPS (Diluted)
$13
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
EPS (Diluted)
$33
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
25%

See Also

What is Fate Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
-1.6 USD

Based on the financial report for Dec 31, 2023, Fate Therapeutics Inc's EPS (Diluted) amounts to -1.6 USD.

What is Fate Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-4%

Over the last year, the EPS (Diluted) growth was 44%. The average annual EPS (Diluted) growth rates for Fate Therapeutics Inc have been 8% over the past three years , -7% over the past five years , and -4% over the past ten years .